Literature DB >> 10497131

Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

J Aramburu1, M B Yaffe, C López-Rodríguez, L C Cantley, P G Hogan, A Rao.   

Abstract

The flow of information from calcium-mobilizing receptors to nuclear factor of activated T cells (NFAT)-dependent genes is critically dependent on interaction between the phosphatase calcineurin and the transcription factor NFAT. A high-affinity calcineurin-binding peptide was selected from combinatorial peptide libraries based on the calcineurin docking motif of NFAT. This peptide potently inhibited NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells, without affecting the expression of other cytokines that require calcineurin but not NFAT. Substitution of the optimized peptide sequence into the natural calcineurin docking site increased the calcineurin responsiveness of NFAT. Compounds that interfere selectively with the calcineurin-NFAT interaction without affecting calcineurin phosphatase activity may be useful as therapeutic agents that are less toxic than current drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497131     DOI: 10.1126/science.285.5436.2129

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  250 in total

Review 1.  Chemical genetics: ligand-based discovery of gene function.

Authors:  B R Stockwell
Journal:  Nat Rev Genet       Date:  2000-11       Impact factor: 53.242

2.  A second calcineurin binding site on the NFAT regulatory domain.

Authors:  S Park; M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Regulation of myosin heavy chain expression during rat skeletal muscle development in vitro.

Authors:  C E Torgan; M P Daniels
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT.

Authors:  J E Miskin; C C Abrams; L K Dixon
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

Authors:  Michael H A Roehrl; Sunghyun Kang; José Aramburu; Gerhard Wagner; Anjana Rao; Patrick G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

6.  Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology.

Authors:  Ying Gu; Jun Zhang; Ying-Bing Wang; Shao-Wei Li; Hai-Jie Yang; Wen-Xin Luo; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

7.  NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching.

Authors:  Karl J A McCullagh; Elisa Calabria; Giorgia Pallafacchina; Stefano Ciciliot; Antonio L Serrano; Carla Argentini; John M Kalhovde; Terje Lømo; Stefano Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

8.  Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain.

Authors:  You-Qing Cai; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Pharmacol Exp Ther       Date:  2013-02-05       Impact factor: 4.030

9.  Nfatc1 orchestrates aging in hair follicle stem cells.

Authors:  Brice E Keyes; Jeremy P Segal; Evan Heller; Wen-Hui Lien; Chiung-Ying Chang; Xingyi Guo; Dan S Oristian; Deyou Zheng; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

10.  Splice cassette II of Na+,HCO3(-) cotransporter NBCn1 (slc4a7) interacts with calcineurin A: implications for transporter activity and intracellular pH control during rat artery contractions.

Authors:  Andreas A Danielsen; Mark D Parker; Soojung Lee; Walter F Boron; Christian Aalkjaer; Ebbe Boedtkjer
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.